US-based medical device company MicroAire Surgical Instruments announced on Monday that it has acquired NEOSYAD, a French company that developed a breakthrough technology for adipose tissue engineering.
NEOSYAD has received EU MDR approval for its AdiMate device and Adipure single-use kit. AdiMate is designed to optimise operating times by integrating the infiltration, liposuction and adipose tissue preparation (lipofilling) functions due to its patented 'all-in-one' concept and integrated proprietary software.
The protocol integrated in the machine enables tissue purification in less than 10 minutes in a completely automatic way, while guaranteeing unmatched adipose tissue quality and viability.
Jerome Barrillon, MicroAire president, said: "We are thrilled to welcome the NEOSYAD team into the MicroAire family. Their expertise, innovative products and dedication to advancing adipose tissue technologies perfectly align with our mission to enable better patient outcomes and support plastic surgeons worldwide."
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system